,,iii  #aadth ,,congress  #b;d ,session 
,s4 ,,res4 #eif  ,,in ,,the ,,senate    
,,of ,,the ,,united ,,states  ,september
 #bi1 #bjaf,mr4 ,coons 7for himself1    
,mr4 ,kirk1 and ,mr4 ,murphy7 submitted 
the following resolution2 which was     
referred to the ,committee on the       
,judiciary  ,,resolution  ,designating  
,september #bjaf as ,pulmonary ,fibrosis
 ,awareness ,month4  ,whereas pulmonary 
fibrosis is a debilitating and          
ultimately fatal condition that causes  
progressive scarring in the lungs and   
generally has no known definitive cause2
 ,whereas as many as #bjj1jjj           
individuals in the ,united ,states are  
known to suffer from pulmonary fibrosis1
 the majority of whom are between the   
ages of #ej and #ge2 ,whereas the       
average survival rate for the idiopathic
 form of pulmonary fibrosis is just #b4h
 years and up to #hj percent of         
idiopathic pulmonary fibrosis patients  
die within #e years of diagnosis2       
,whereas pulmonary fibrosis takes the   

lives of #dj1jjj individuals in the     
,united ,states each year1 approximately
 #a death every #ac minutes2 ,whereas   
many patients with pulmonary fibrosis   
are misdiagnosed for #a year or longer  
after the patients are presenting with  
pulmonary fibrosis symptoms2 ,whereas as
 of ,september #bjaf1 there are no      
biomarkers for screening and testing for
 pulmonary fibrosis2 ,whereas a cure or 
drug that is effective for all pulmonary
 fibrosis patients that would extend    
life or universally improve symptoms    
does not exist2 ,whereas the symptoms of
 pulmonary fibrosis vary from person to 
person and include shortness of breath1 
a dry cough1 fatigue1 weight loss1 and  
aching muscles and joints2 ,whereas     
volunteers1 researchers1 caregivers1 and
 medical professionals are working to   
improve the quality of life for         
individuals with pulmonary fibrosis and 
the families of those individuals2 and  
,whereas developing more effective      
treatments for pulmonary fibrosis and   

providing access to quality care to     
individuals with pulmonary fibrosis     
requires increased research1 education1 
and community support services3 ,now1   
therefore1 be it  ,that the ,senate--   
7#a7 designates ,september #bjaf as     
,pulmonary ,fibrosis ,awareness ,month2 
7#b7 supports the goals and ideals of   
,pulmonary ,fibrosis ,awareness ,month2 
7#c7 continues to support more robust   
and accelerated research to develop more
 effective treatments for pulmonary     
fibrosis and to ultimately find a cure  
for the disease2  7#d7 recognizes the   
courage and contributions of individuals
 with pulmonary fibrosis who participate
 in vital clinical trials to advance the
 knowledge of the disease2 and  7#e7    
commends the dedication of              
organizations1 volunteers1 researchers1 
and millions of individuals in the      
,united ,states and abroad working to   
improve the quality of life for         
individuals with pulmonary fibrosis and 
the families of those individuals4